These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 19509205)

  • 1. Taking the stress out of insulin initiation in type 2 diabetes mellitus.
    Laubscher T; Regier L; Jensen B
    Can Fam Physician; 2009 Jun; 55(6):608-11. PubMed ID: 19509205
    [No Abstract]   [Full Text] [Related]  

  • 2. HbA(1c) targets for type 2 diabetes: how many, …how far!
    Giugliano D; Ceriello A; Esposito K
    Diabetes Res Clin Pract; 2012 Jun; 96(3):414-5. PubMed ID: 21963106
    [No Abstract]   [Full Text] [Related]  

  • 3. Course of glycaemia in poorly controlled type 2 diabetes patients 2.5 years after optimizing oral treatment in general practice.
    Berghout LM; Gorter KJ; Rutten GE
    Eur J Gen Pract; 2006; 12(2):80-2. PubMed ID: 16945883
    [No Abstract]   [Full Text] [Related]  

  • 4. Summaries for patients. Comparison of two types of insulin added to diabetes pills in poorly controlled type 2 diabetes.
    Ann Intern Med; 2008 Oct; 149(8):I-46. PubMed ID: 18936498
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of biphasic insulin aspart 30 given three times daily or twice daily in combination with metformin versus oral antidiabetic drugs alone in patients with poorly controlled type 2 diabetes: a 16-week, randomized, open-label, parallel-group trial conducted in russia.
    Ushakova O; Sokolovskaya V; Morozova A; Valeeva F; Zanozina O; Sazonova O; Zhadanova E; Starceva M; Kazakova E; Saifullina M; Shapiro I; Tarasov A; Al-Tayar B; Starkova N
    Clin Ther; 2007 Nov; 29(11):2374-84. PubMed ID: 18158078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Insulin therapy in patients with type 2 diabetes].
    Siegmund T; Schumm-Draeger PM
    MMW Fortschr Med; 2008 May; 150(18):32-5; quiz 36. PubMed ID: 18533606
    [No Abstract]   [Full Text] [Related]  

  • 7. Intensifying insulin therapy with insulin analog premixes: transitioning from basal insulin in type 2 diabetes.
    Shanik MH
    Diabetes Technol Ther; 2012 Jun; 14(6):533-9. PubMed ID: 22364142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mealtime 50/50 basal + prandial insulin analogue mixture with a basal insulin analogue, both plus metformin, in the achievement of target HbA1c and pre- and postprandial blood glucose levels in patients with type 2 diabetes: a multinational, 24-week, randomized, open-label, parallel-group comparison.
    Robbins DC; Beisswenger PJ; Ceriello A; Goldberg RB; Moses RG; Pagkalos EM; Milicevic Z; Jones CA; Sarwat S; Tan MH
    Clin Ther; 2007 Nov; 29(11):2349-64. PubMed ID: 18158076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [HbA1c is too high despite tablets. With single injections toward better blood glucose values].
    MMW Fortschr Med; 2004 Mar; 146(10):43. PubMed ID: 15347083
    [No Abstract]   [Full Text] [Related]  

  • 10. [Control of diabetes mellitus].
    Daweke H
    Verh Dtsch Ges Inn Med; 1990; 96():175-82. PubMed ID: 2092437
    [No Abstract]   [Full Text] [Related]  

  • 11. [Insulin therapy in type 2 diabetes].
    Hummel M
    MMW Fortschr Med; 2011 Jun; 153(23):56-9, 61; quiz 62. PubMed ID: 21688497
    [No Abstract]   [Full Text] [Related]  

  • 12. [GLP-1: a new therapeutic principle for the treatment of type 2 diabetes mellitus].
    Menge BA; Meier JJ; Schmidt WE
    Med Klin (Munich); 2010 Mar; 105(3):163-75. PubMed ID: 20349294
    [No Abstract]   [Full Text] [Related]  

  • 13. Metformin as an adjunctive therapy for NIDDM.
    Waterman PE
    Nurse Pract; 1996 Apr; 21(4):150-2. PubMed ID: 8801483
    [No Abstract]   [Full Text] [Related]  

  • 14. ["Good" blood glucose values, "bad" HbA1c].
    Osterwalder P; Furrer J
    Praxis (Bern 1994); 1998 Sep; 87(39):1260-2. PubMed ID: 9793418
    [No Abstract]   [Full Text] [Related]  

  • 15. [Type 2 diabetes. Lixisenatide - effective in combination].
    MMW Fortschr Med; 2013 Aug; 155(14):62-3. PubMed ID: 24006601
    [No Abstract]   [Full Text] [Related]  

  • 16. Intensive Glycemic Control in Type 2 Diabetes Mellitus -- A Balancing Act of Latent Benefit and Avoidable Harm: A Teachable Moment.
    Rodriguez-Gutierrez R; Lipska KJ; McCoy RG
    JAMA Intern Med; 2016 Mar; 176(3):300-1. PubMed ID: 26882223
    [No Abstract]   [Full Text] [Related]  

  • 17. [Intensified therapy with insulin analogs in type 2 diabetes: normalizing metabolism and maintaining body weight?].
    Jungmann E; Helling T; Jungmann G; Mertens C; Snelting U
    MMW Fortschr Med; 2000 Oct; 142(43):48. PubMed ID: 11098614
    [No Abstract]   [Full Text] [Related]  

  • 18. Summaries for patients. Inhaled insulin with or instead of oral medications for type 2 diabetes.
    Ann Intern Med; 2005 Oct; 143(8):I28. PubMed ID: 16230717
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of diabetes mellitus: implications of the use of oral agents.
    Rao SV; Bethel MA; Feinglos MN
    Am Heart J; 1999 Nov; 138(5 Pt 1):S334-7. PubMed ID: 10539794
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparative assessment of the efficacy and safety of acarbose and metformin combined with premixed insulin in patients with type 2 diabetes mellitus.
    Wu H; Liu J; Lou Q; Liu J; Shen L; Zhang M; Lv X; Gu M; Guo X
    Medicine (Baltimore); 2017 Sep; 96(35):e7533. PubMed ID: 28858080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.